Immunomedics, Inc.
Company Information

300 The American Rd
Morris Plains, NJ, 07950 United States
(973) 605-8200

Immunomedics, Inc. Rankings

Russell 2000 (June 2015)

Top 3 Competitors

Unlock more access to Hoover’s!

  • Build customized email lists 24/7, based on your best customer profile.
  • Learn more about the companies you want to sell to. Hoover’s has reports on 85+ million companies and 900 industries. 65,000 data points are updated each day.
  • Get real insight written by real people – exclusive research and reviews by our in-house Editorial staff.
  • We can deliver our data to your desktop, to Excel, direct to your CRM, into your custom app, or via mobile.

Call (866) 473-3932 today to get started with a FREE TRIAL!


Immunomedics, Inc. Company Profile

Immunomedics is a MAb scientist, mixing up monoclonal antibody (MAb) medicines to treat cancer, autoimmune conditions, and other diseases. Its lead product, epratuzumab, is in development for the treatment of lupus; biopharmaceutical firm UCB has licensed the drug for further applications in autoimmune diseases. Immunomedics is also conducting clinical trials for epratuzumab as an oncology treatment for non-Hodgkin's lymphoma. Other drugs in clinical trials aim to treat various cancers, including pancreatic cancer and multiple myeloma. It also makes diagnostic imaging products; its majority-owned IBC Pharmaceuticals develops radiotherapeutics for applications in oncology treatments.